Leder; Philip

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leder; Philip.The latest application filed is for "7b2 knockout transgenic animals as models of endocrine disease".

Company Profile

0.15.6

Leder; Philip - Chestnut Hill MA
Leder; Philip - Bethesda MD
Leder; Philip - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
7B2 Knockout transgenic animals as models of endocrine disease App 20090004657 - Westphal; Christoph H. ; et al.	2009-01-01
7B2 knockout transgenic animals as models of endocrine disease Grant 7,348,156 - Westphal , et al. March 25, 2	2008-03-25
DNA encoding IgE Receptor .alpha.-subunit or fragment thereof Grant 7,202,333 - Leder , et al. April 10, 2	2007-04-10
7B2 knockout transgenic animals as models of endocrine disease App 20050086709 - Westphal, Christoph H. ; et al.	2005-04-21
Eotaxin: an eosinophil chemoattractant Grant 6,780,973 - Luster , et al. August 24, 2	2004-08-24
Compounds regulating cell proliferation and differentiation App 20040097408 - Leder, Philip ; et al.	2004-05-20
Methods, compositions and articles of manufacture useful for treating mammary tumors App 20030225026 - Elson, Ari ; et al.	2003-12-04
Formin-2 nucleic acids and polypeptides and uses thereof App 20030170683 - Leder, Philip ; et al.	2003-09-11
Methods and uses for transposon-based gene targeting Grant 6,504,081 - Westphal , et al. January 7, 2	2003-01-07
Formin-2 nulceic acids and polypeptides and uses thereof App 20020098489 - Leder, Philip ; et al.	2002-07-25
Nucleic acid encoding eotaxin Grant 6,403,782 - Luster , et al. June 11, 2	2002-06-11
Modulation of endothelial cell proliferation with IP-10 Grant 5,824,299 - Luster , et al. October 20, 1	1998-10-20
System for assaying binding to a heparin-binding growth factor receptor Grant 5,789,182 - Yayon , et al. August 4, 1	1998-08-04
Cell death protein Grant 5,674,734 - Leder , et al. October 7, 1	1997-10-07
Use of the cytokine IP-10 as an anti-tumor agent Grant 5,474,981 - Leder , et al. December 12, 1	1995-12-12
Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor Grant 5,270,197 - Yayon , et al. December 14, 1	1993-12-14
Animal model for benign prostatic disease Grant 5,175,383 - Leder , et al. December 29, 1	1992-12-29
DNA encoding IgE receptor alpha-subunit or fragment thereof Grant 4,962,035 - Leder , et al. October 9, 1	1990-10-09
Transgenic non-human mammals Grant 4,736,866 - Leder , et al. April 12, 1	1988-04-12
Protein from SV40 recombinants Grant 4,599,308 - Hamer , et al. July 8, 1	1986-07-08
Detecting rearranged human c-myc DNA fragments associated with oncogenes Grant 4,542,096 - Leder September 17, 1	1985-09-17

Company Registrations

SEC

0001083219

LEDER PHILIP

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.